Trials / Completed
CompletedNCT04561895
Adipokine Genetic Variations in predictingNAFLD Progression to NASH in Egyptian Patients
Genetic Variations in Adipokine to Improve Risk Prediction for NAFLD and Its Progression to NASH in Egyptian Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 224 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- —
Summary
Due to the limited data concerning Egyptian population. authors aimed to investigate the differentadipokine gene polymorphism related to non alcoholic fatty liver disease incidence, prognosis and progression to steotosis and also to find different related factors including obesitu, diabetes and liver enzymes level
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | DNA extraction | investigation of DNA polymorphism in patients suffering from NAFLD |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2020-09-15
- Completion
- 2020-09-16
- First posted
- 2020-09-24
- Last updated
- 2020-09-24
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04561895. Inclusion in this directory is not an endorsement.